论文部分内容阅读
目的:探讨骨髓间充质干细胞移植治疗脑梗死临床疗效。方法:选取进行治疗的脑梗死86例患者作为研究对象,按照随机分组的方法分为对照组和研究组,每组43例。结果:研究组在治疗后4周、12周和5个月Fugl-Meyer运动情况评分均明显优于对照组(P<0.05),研究组在治疗后4周、12周和5个月功能独立性评分均明显优于对照组(P<0.05)。结论:采用骨髓间充质干细胞移植治疗脑梗死临床疗效明确,应加强临床推广。
Objective: To investigate the clinical effect of bone marrow mesenchymal stem cell transplantation in the treatment of cerebral infarction. Methods: Totally 86 patients with cerebral infarction were enrolled in this study. They were divided into control group and study group according to the method of randomization, with 43 cases in each group. Results: The scores of Fugl-Meyer movement in study group were significantly better than those in control group at 4, 12 and 5 months after treatment (P <0.05). The study group was independent of function after 4 weeks, 12 weeks and 5 months Sex scores were significantly better than the control group (P <0.05). Conclusion: The clinical efficacy of bone marrow mesenchymal stem cell transplantation in the treatment of cerebral infarction is clear. Clinical application should be strengthened.